Month: December 2019

(Bloomberg) — Biogen Inc. said it plans to resume previous studies of its once-abandoned drug for Alzheimer’s disease, rolling out detailed trial data to a standing-room-only gathering of scientists in California.The company’s in-depth presentation at the Clinical Trials on Alzheimer’s Disease conference in San Diego on Thursday marked a climax in a monthslong saga that has seen patients’ hopes dashed and revived, and Biogen’s stock price plummet and then rebound.It was the first in-depth look Biogen has provided at the experimental treatment, known as aducanumab, since reviving it in October. In March, Biogen declared two studies of the medicine failures …read more […]

How do we determine whether Aspen Technology, Inc. (NASDAQ:AZPN) makes for a good investment at the moment? We analyze the sentiment of a select group of the very best investors in the world, who spend immense amounts of time and resources studying companies. They may not always be right (no one is), but data shows […] …read more […]

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than 700 world-class investment firms that we track and now have access to the collective wisdom contained in […] …read more […]

(Bloomberg) — Steve Cohen told his hedge fund’s clients that owning a Major League Baseball team won’t supplant his true passion: investing.The billionaire, nearing a deal that would give him control of the New York Mets, said in a letter to investors that the move won’t change his role at Point72 Asset Management, where he is chief executive officer.Baseball is more about fulfilling a childhood dream. Cohen rooted for the Mets while growing up on Long Island and attended games at the Polo Grounds, where the team started out.“It has always been a dream of mine to be a majority …read more […]

(Bloomberg) — Amazon.com Inc. claims it lost a Pentagon cloud contract valued at as much as $10 billion because of political interference by President Donald Trump, according to the judge overseeing the case.Federal Claims Court Judge Patricia Campbell-Smith said during a court proceeding last week that Amazon’s lawsuit argues that the Pentagon didn’t award the cloud deal to Microsoft Corp. on the basis of a fair evaluation of the companies’ bids.“Plaintiff contends that the procurement process was compromised and negatively affected by the bias expressed publicly by the president and commander in chief Donald Trump against plaintiff,” Campbell-Smith said in …read more […]

Hedge funds are known to underperform the bull markets but that’s not because they are terrible at stock picking. Hedge funds underperform because their net exposure in only 40-70% and they charge exorbitant fees. No one knows what the future holds and how market participants will react to the bountiful news that floods in each […] …read more […]

Does the December share price for Las Vegas Sands Corp. (NYSE:LVS) reflect what it’s really worth? Today, we will… …read more […]

Significant additional regulatory requirements or delays in returning Boeing Co’s 737 MAX to commercial service could cause it to cut or temporarily halt production of the aircraft, it said in a letter seen by Reuters on Thursday. Boeing said it does not expect 737 MAX order cancellations due to the grounding of its best-selling single-aisle jet to have a material impact on revenues or earnings. The 737 MAX, Boeing’s best-selling plane, has been grounded worldwide since March after crashes in Indonesia and Ethiopia that killed 346 people in the span of five months. …read more […]

As 2019 draws to a close, let’s reflect on some of the biggest stories of the year for cannabis… and take a peek at what lies ahead for 2020.
We recently invited our friends Justin Strekal from the National Organization for the Reform of Marijuana Laws (NORML) and Morgan Fox from the National Cannabis Industry Association to sit down with us for our first ever “Legislative Roundtable.”
There are few individuals who better understand the inner workings of cannabis legislation than Justin and Morgan.
For a decade, they have had their fingers on the pulse of what’s going on in Washington, D.C. – …read more […]